天麻素联合胞磷胆碱治疗后循环缺血性眩晕临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R441.2

基金项目:


Clinical Study on Gastrodin Combined with Citicoline for Posterior Circulation Ischemic Vertigo
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察天麻素联合胞磷胆碱治疗后循环缺血性眩晕(PCIV) 的疗效。方法:回顾性选取PCIV 患者104例,根据治疗方案不同分为对照组50例和联合组54例。2组均接受常规干预治疗,对照组在常规干预 治疗基础上给予胞磷胆碱钠胶囊口服治疗,联合组在对照组基础上给予天麻素注射液治疗。2组均治疗14 d。 评价2组临床疗效,比较2组治疗前后眩晕评定量表评分系统(DARS) 评分、眩晕障碍量表的筛查表(DHI-S) 评分、脑动脉血流速度及血液流变学指标[血浆黏度(PV)、全血高切黏度(HSV)、全血低切黏度(LSV)、红 细胞比容(Hct) ],统计2组不良反应发生情况。结果:联合组总有效率为96.30%,高于对照组78.00%(P< 0.05)。治疗后,2组DARS评分与DHI-S评分均较治疗前降低(P<0.05),且联合组DARS评分与DHI-S评分 均低于对照组(P<0.05)。治疗后,2组基底动脉平均血流速度、左侧椎动脉平均血流速度及右侧椎动脉平均 血流速度均较治疗前升高(P<0.05),且联合组基底动脉平均血流速度、左侧椎动脉平均血流速度及右侧椎动 脉平均血流速度均高于对照组(P<0.05)。治疗后,2组PV、HSV、LSV及Hct均较治疗前降低(P<0.05), 且联合组PV、HSV、LSV及Hct均低于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P> 0.05)。结论:天麻素联合胞磷胆碱治疗PCIV患者临床疗效显著,可能通过改善患者血液流变学指标进而缓解 眩晕症状。

    Abstract:

    Abstract:Objective:To observe the curative effect of gastrodin combined with citicoline for posterior circulation ischemic vertigo (PCIV). Methods: A total of 104 cases of PCIV patients were retrospectively selected and divided into the control group and the combination group according to different treatment schemes, with 50 and 54 cases in each group respectively. Both groups received routine intervention treatment. The control group was given oral administration of Cytidine Sodium Capsules based on the treatment of routine intervention treatment, and the combination group was additionally treated with Gastrodin Injection based on the treatment of the control group. Both groups were treated for 14 days. Clinical effects were evaluated in the two groups. The scores of Dizziness Assessment Rating Scale (DARS) and Dizziness Handicap Inventory-Screening version (DHI-S), cerebral artery blood flow velocity, and hemorheological indicators [plasma viscosity (PV), whole blood high-shear viscosity (HSV), whole blood low-shear viscosity (LSV), and hematocrit (Hct)] were compared before and after treatment between the two groups, and the incidence of adverse reactions was counted in the two groups. Results: The total clinical effective rate was 96.30% in the combination group,higher than that of 78.00% in the control group (P<0.05). After treatment, the scores of DARS and DHI-S in the two groups were decreased when compared with those before treatment (P<0.05),and the scores in the combination group were lower than those in the control group (P<0.05). After treatment,the scores of mean blood flow velocity of the basilar artery, left vertebral artery, and right vertebral artery in the two groups were increased when compared with those before treatment (P<0.05),and each velocity in the combination group was higher than that in the control group (P<0.05). After treatment,PV,HSV,LSV,and Hct in the two groups were decreased when compared with those before treatment (P<0.05), and the four indicators in the combination group were lower than those in the control group (P<0.05). There was no significant difference being found in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Gastrodin combined with citicoline has a significant clinical effect in the treatment of PCIV,which may alleviate vertigo symptoms by improving the patient's hemorheological indicators.

    参考文献
    相似文献
    引证文献
引用本文

宣方杰,王碧浪.天麻素联合胞磷胆碱治疗后循环缺血性眩晕临床研究[J].新中医,2024,56(9):41-45

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-13
  • 出版日期:
文章二维码